Search scope:
排序: Display mode:
Translational medicine in hepatocellular carcinoma
Qiang Gao, Yinghong Shi, Xiaoying Wang, Jian Zhou, Shuangjian Qiu, Jia Fan
Frontiers of Medicine 2012, Volume 6, Issue 2, Pages 122-133 doi: 10.1007/s11684-012-0193-7
Keywords: hepatocellular carcinoma molecular classification molecular targeted therapies tumor microenvironment
Molecular classification and molecular targeted therapy of cancer
Miao Xu, Jianyong Shao, Yixin Zeng
Frontiers of Medicine 2013, Volume 7, Issue 2, Pages 147-149 doi: 10.1007/s11684-013-0274-2
Molecular markers and pathogenically targeted therapy in non-small cell lung cancer
Bo PENG BA , Jinnong ZHANG MD , Jamile S. WOODS MD , Wei PENG MD, PhD
Frontiers of Medicine 2009, Volume 3, Issue 3, Pages 245-255 doi: 10.1007/s11684-009-0044-3
Keywords: lung cancer carcinoma non-small cell lung cancer molecular markers targeted therapy
Pengming SUN PhD, MD , Jalid SEHOULI PhD, MD , Lihui WEI BM ,
Frontiers of Medicine 2009, Volume 3, Issue 3, Pages 256-264 doi: 10.1007/s11684-009-0052-3
Keywords: target therapy gynecologic malignant tumors clinical trail molecular medicine
Liangqian Tong, Ming Zhao, Shu Zhu, Jing Chen
Frontiers of Medicine 2011, Volume 5, Issue 4, Pages 379-387 doi: 10.1007/s11684-011-0162-6
Keywords: nanoparticles superparamagnetic iron oxide targeted therapy molecular imaging cancer
Yue Yu, Jie He
Frontiers of Medicine 2013, Volume 7, Issue 2, Pages 157-171 doi: 10.1007/s11684-013-0272-4
Keywords: non-small-cell lung cancer molecular typing individualized medicine molecular-targeted therapy gene expression
Peter B. Alexander,Xiao-Fan Wang
Frontiers of Medicine 2015, Volume 9, Issue 2, Pages 134-138 doi: 10.1007/s11684-015-0396-9
Drug resistance is a major factor that limits the efficacy of targeted cancer therapies.mechanisms of resistance to receptor tyrosine kinase inhibitors, which are the most prevalent class of targeted
Keywords: targeted therapy drug resistance receptor tyrosine kinases cancer
Precision medicine in acute lymphoblastic leukemia
Ching-Hon Pui
Frontiers of Medicine 2020, Volume 14, Issue 6, Pages 689-700 doi: 10.1007/s11684-020-0759-8
Keywords: acute lymphoblastic leukemia molecular therapeutics targeted therapy tyrosine kinase inhibitors immunotherapy
Molecular network-based intervention brings us closer to ending the HIV pandemic
Xiaoxu Han, Bin Zhao, Minghui An, Ping Zhong, Hong Shang
Frontiers of Medicine 2020, Volume 14, Issue 2, Pages 136-148 doi: 10.1007/s11684-020-0756-y
Keywords: human immunodeficiency virus type 1 molecular cluster transmission cluster risk network targeted intervention
Vaccine therapies for chronic hepatitis B: can we go further?
Yumei Wen, Xuanyi Wang, Bin Wang, Zhenhong Yuan
Frontiers of Medicine 2014, Volume 8, Issue 1, Pages 17-23 doi: 10.1007/s11684-014-0313-7
Chronic hepatitis B is a major health burden worldwide. In addition to the recent progress in antiviral treatment, therapeutic vaccination is a promising new strategy for the control of chronic hepatitis B. On the basis of the major specific and non-specific immune dysregulations and defects in chronic hepatitis B patients, this paper presents the peptide and protein-based, DNA-based, cell-based, and antigen-antibody-based therapeutic vaccines, which have undergone clinical trials. The advantages, disadvantages, and future perspectives for these therapeutic vaccines are discussed.
Keywords: chronic hepatitis B therapeutic antigen-antibody complexes DNA vaccine
Chimeric antigen receptor T cell therapies for acute myeloid leukemia
Bin Gu, Jianhong Chu, Depei Wu
Frontiers of Medicine 2020, Volume 14, Issue 6, Pages 701-710 doi: 10.1007/s11684-020-0763-z
Keywords: acute myeloid leukemia CAR T immunotherapy
Frontiers of Medicine 2023, Volume 17, Issue 2, Pages 275-289 doi: 10.1007/s11684-022-0945-y
Keywords: epidermal growth factor receptor ErbB receptors HM781-36B nasopharyngeal carcinoma molecular targeted
Liver cell therapies: cellular sources and grafting strategies
Frontiers of Medicine 2023, Volume 17, Issue 3, Pages 432-457 doi: 10.1007/s11684-023-1002-1
Keywords: liver regeneration hepatocytes cholangiocytes stem cells organoids regulatory mechanisms transplantation/grafting strategies
Influence of Survivin-targeted siRNA on the biological features of colorectal carcinoma cells
XIONG Ying, GUO Wen, LI Ting, LI Ke
Frontiers of Medicine 2007, Volume 1, Issue 3, Pages 304-307 doi: 10.1007/s11684-007-0058-7
Keywords: control therapy influence Survivin-1 colorectal carcinoma
Wen-Can Huang,Wenjie Wang,Wei Wang,Yanan Hao,Changhu Xue,Xiangzhao Mao,
Engineering doi: 10.1016/j.eng.2023.05.024
Keywords: Polysaccharides Chitosan Hydrogels Oral delivery Intestine-targeted
Title Author Date Type Operation
Translational medicine in hepatocellular carcinoma
Qiang Gao, Yinghong Shi, Xiaoying Wang, Jian Zhou, Shuangjian Qiu, Jia Fan
Journal Article
Molecular classification and molecular targeted therapy of cancer
Miao Xu, Jianyong Shao, Yixin Zeng
Journal Article
Molecular markers and pathogenically targeted therapy in non-small cell lung cancer
Bo PENG BA , Jinnong ZHANG MD , Jamile S. WOODS MD , Wei PENG MD, PhD
Journal Article
Molecular targeted therapy of gynecological malignant tumors: the development and challenge, from laboratory
Pengming SUN PhD, MD , Jalid SEHOULI PhD, MD , Lihui WEI BM ,
Journal Article
Synthesis and application of superparamagnetic iron oxide nanoparticles in targeted therapy and imaging
Liangqian Tong, Ming Zhao, Shu Zhu, Jing Chen
Journal Article
Molecular classification of non-small-cell lung cancer: diagnosis, individualized treatment, and prognosis
Yue Yu, Jie He
Journal Article
Resistance to receptor tyrosine kinase inhibition in cancer: molecular mechanisms and therapeutic strategies
Peter B. Alexander,Xiao-Fan Wang
Journal Article
Molecular network-based intervention brings us closer to ending the HIV pandemic
Xiaoxu Han, Bin Zhao, Minghui An, Ping Zhong, Hong Shang
Journal Article
Vaccine therapies for chronic hepatitis B: can we go further?
Yumei Wen, Xuanyi Wang, Bin Wang, Zhenhong Yuan
Journal Article
Chimeric antigen receptor T cell therapies for acute myeloid leukemia
Bin Gu, Jianhong Chu, Depei Wu
Journal Article
A small-molecule pan-HER inhibitor alone or in combination with cisplatin exerts efficacy against nasopharyngeal carcinoma
Journal Article
Influence of Survivin-targeted siRNA on the biological features of colorectal carcinoma cells
XIONG Ying, GUO Wen, LI Ting, LI Ke
Journal Article